semaglutide
7 Lies About Semaglutide vs Tirzepatide Safety
Less than 1% of patients on semaglutide or tirzepatide experience serious adverse events, according to recent trial data. Both drugs are approved for obesity and type 2 diabetes, yet headlines often inflate the risks. In the next sections I unpack the numbers, compare the two agents, and show where the